Serge Saxonov was appointed CEO of 10X Genomics on August 14, 2025, while market figures questioned funding trends and acquisitions.
2 reports, 2 independent
Updated Aug 14
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Serge Saxonov was appointed CEO of 10X Genomics on August 14, 2025, while market figures questioned funding trends and acquisitions.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
10X Genomics
American biotechnology company
Nothing else this week.
-
Patrick Donnelly
researcher ORCID ID = 0000-0002-9910-0794
Nothing else this week.
Coverage
Newest first; wire copies grouped- StockStory10x Genomics’s Q2 Earnings Call: Our Top 5 Analyst Questions 10x Genomics delivered second quarter results that exceeded Wall Street’s expectations, but the market responded negatively, reflecting co
- Simply Wall St.Earnings Beat: 10x Genomics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Shareholders might have noticed that 10x Genomics, Inc. (NASDAQ:TXG) filed its quarterly re